← All organizations

Polyclinique du Parc, 31078 Toulouse, France

Academic/Hospital

Also known as: Védrines, Philippe, M.D.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Last known activity

Jul 23, 2018

Timeline

No events for the selected filters.

Drugs by trial phase (2 distinct, 2 trials)

Phase 4 (1 own, 0 via acquisition)

azathioprine

Phase 2 (1 own, 0 via acquisition)

cetuximab

Indications

Studied for

Head and Neck Neoplasms

Recent trials (3)

NCT03580876Lead sponsorPhase 4Jul 23, 2018
NCT03580876Reponsible party - principal investigatorPhase 4Jul 23, 2018
NCT01237483Overall official - principal investigatorPhase 2Oct 1, 2010

Details

Last known activity: Jul 23, 2018